why choose us

Clinical Trials Search

Showing 6,180 of 132,085 result(s)
SGLT2 Inhibitor Therapy in Cystic Fibrosis-related Diabetes

Status: NOT_YET_RECRUITING

Condition: Cystic Fibrosis-related Diabetes

Interventions: Sodium glucose co-transporter 2 inhibitor

Date: 2023-11-20

Eyelid Androgen Treatment in Dry Eye

Status: Completed

Condition: Aqueous Tear Deficiency

Interventions: Testosterone gel applied to eyelids twice per day

Date: 2023-11-20

HyBryte (Synthetic Hypericin) Versus Valchlor (Mechlorethamine) in the Treatment of CTCL

Status: Completed

Condition: Cutaneous T-Cell Lymphoma;Mycosis Fungoides

Interventions: HyBryte is synthetic hypericin formulated as a 0.25% hypericin ointment.

Date: 2023-11-20

A Trial to Learn if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Participants With Follicular Lymphoma and Marginal Zone Lymphoma

Status: Completed

Condition: Relapsed;Refractory Follicular Lymphoma

Interventions: Administered by intravenous (IV) infusion

Date: 2023-11-20

Cardiac Performance System Data Collection Study - Minnesota

Status: Completed

Condition: Cardiac Disease

Interventions: Participants will be asked to wear the Cardiac Performance System, a non-invasive sensor device on their upper abdomen.
The Cardiac Performance S

Date: 2023-11-20

A Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid Tumours

Status: NOT_YET_RECRUITING

Condition: Advanced Solid Tumor

Interventions: FPI-2053 is a bispecific antibody that targets EGFR and cMET

Date: 2023-11-20

A Study of LY3971297 in Healthy Participants and Participants With Obesity and Hypertension

Status: NOT_YET_RECRUITING

Condition: Healthy

Interventions: Administered SC

Date: 2023-11-20

Evaluating the Use of Photodynamic Therapy to Treat Facial Cutaneous Squamous Cell Carcinoma in Situ (isSCC)

Status: Completed

Condition: Facial Cutaneous Squamous Cell Carcinoma in Situ

Interventions: Participants will have their facial isSCC prepped then treated with Aminolevulinic Acid 20% Topical Solution (Levulan® Kerastick® Applicators) (ALA),

Date: 2023-11-20

Penetration-enhanced Direct DBD Non-thermal Plasma for Hair Loss

Status: ACTIVE_NOT_RECRUITING

Condition: Androgenetic Alopecia

Interventions: Cold plasma is generated and applied to the scalp area, which was previously soaked with normal saline

Date: 2023-11-20

Effects of an Algorithmically Enhanced Personalized Music-based Intervention in Patients With Dementia

Status: Completed

Condition: Music

Interventions: An algorithmically enhanced personalized music-based intervention

Date: 2023-11-20